Tower Research Capital (TRC)’s Edesa Biotech EDSA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.76K | Buy |
2,343
+1,151
| +97% | +$2.34K | ﹤0.01% | 4272 |
|
2025
Q1 | $2.91K | Sell |
1,192
-2,246
| -65% | -$5.48K | ﹤0.01% | 4489 |
|
2024
Q4 | $5.78K | Buy |
3,438
+2,422
| +238% | +$4.07K | ﹤0.01% | 4244 |
|
2024
Q3 | $4.52K | Sell |
1,016
-1,430
| -58% | -$6.36K | ﹤0.01% | 4516 |
|
2024
Q2 | $10.5K | Buy |
2,446
+372
| +18% | +$1.59K | ﹤0.01% | 4147 |
|
2024
Q1 | $8.69K | Buy |
2,074
+510
| +33% | +$2.14K | ﹤0.01% | 3976 |
|
2023
Q4 | $7.15K | Buy |
1,564
+347
| +29% | +$1.59K | ﹤0.01% | 4651 |
|
2023
Q3 | $5.39K | Hold |
1,217
| – | – | ﹤0.01% | 4728 |
|
2023
Q2 | $6.91K | Sell |
1,217
-160
| -12% | -$909 | ﹤0.01% | 4621 |
|
2023
Q1 | $9K | Buy |
1,377
+456
| +50% | +$2.98K | ﹤0.01% | 4480 |
|
2022
Q4 | $14K | Sell |
921
-809
| -47% | -$12.3K | ﹤0.01% | 3498 |
|
2022
Q3 | $11K | Buy |
1,730
+1,229
| +245% | +$7.81K | ﹤0.01% | 4433 |
|
2022
Q2 | $6K | Buy |
501
+75
| +18% | +$898 | ﹤0.01% | 4916 |
|
2022
Q1 | $9K | Buy |
426
+380
| +826% | +$8.03K | ﹤0.01% | 4445 |
|
2021
Q4 | $2K | Sell |
46
-422
| -90% | -$18.3K | ﹤0.01% | 5614 |
|
2021
Q3 | $24K | Buy |
+468
| New | +$24K | ﹤0.01% | 3555 |
|
2016
Q4 | – | Sell |
-2
| Closed | -$1K | – | 3932 |
|
2016
Q3 | $1K | Sell |
2
-1
| -33% | -$500 | ﹤0.01% | 3281 |
|
2016
Q2 | $3K | Sell |
3
-2
| -40% | -$2K | ﹤0.01% | 3677 |
|
2016
Q1 | $7K | Buy |
+5
| New | +$7K | ﹤0.01% | 2351 |
|
2015
Q4 | – | Hold |
0
| – | – | – | 4599 |
|